We are thrilled to have our very own Liang Schweizer join the Life Science Cares Boston Board of Advisors! We are proud to see our leaders not only passionate about developing HiFiBiO’s lead candidates through clinical trials for patients with high unmet needs, but also care deeply about the community around us.
We are excited to welcome Liang Schweizer, Founder, Chairperson, and CEO of HiFiBiO Therapeutics, to our Boston Board of Advisors! She is committed to making a broader impact in the community and is thrilled to join us in our efforts to support community-based organizations and programs that provide access to basic needs, education, and economic opportunity. Welcome, Liang! HiFiBiO Therapeutics is pioneering curative immunotherapies for patients with high unmet medical needs. The company is targeting the root cause of disease through its unique Drug Intelligence Science (DIS®) platform. DIS® enables the deep understanding of cellular pathology across various diseases through proprietary single cell technology and AI/ML analytics. This platform is being deployed in target discovery, antibody selection, and predictive biomarker identification to achieve enhanced clinical success for patients.
